Comprehensive Insights Provided into the Epidemiology Segments and Forecasts, the Future Growth Potential of Diagnosis Rate, Disease Progression, and Diagnostic GuidelinesDublin, Dec. 05, 2024 (GLOBE ...
Discover a study that examined the efficacy and safety of pemafibrate in 360 patients with MASLD and hypertriglyceridaemia.
Switch Therapeutics Inc. has announced its first development candidate, a liver-sparing APOE (apolipoprotein E) RNAi therapy for treatment of Alzheimer’s disease in APOE4 carriers. Switch’s ...
James Marlin stood at a crossroads. After a 25-year career in the medical field, primarily in orthopedic sales and surgical ...
Many people assume most individuals addicted to opioids are young. But there’s also a significant population of 65+ addicted ...
Organically Human on MSN2 小时
Pay Attention To These 40 Autoimmune Issues
Scleroderma is a chronic autoimmune disease that primarily affects the skin, causing it to thicken and harden. In severe ...
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
AstraZeneca's IMFINZI® (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following ...
It’s like that time you accidentally drank spoiled milk—just a lot worse. Liver or Pancreas Issues: Inflammation of the liver ...
So Kahler got a doctorate in clinical psychology and set out to learn everything about addiction. Today, he's a professor of ...
Astellas Pharma US, Inc. (TSE: 4503, Head of US Commercial: Michael Petroutsas, "Astellas") today announced the launch ...
A new editorial was published in Oncotarget's Volume 15 on November 22, 2024, entitled "B7-H4: A potential therapeutic target in adenoid cystic carcinoma." ...